.

Deeper Knowledge, Faster

  • Predict branded drug patent expiration
  • Uncover prior art in expired and abandoned patents
  • Drug patents in 130+ countries

► See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Fuji
Queensland Health
Argus Health
Teva
Fish and Richardson
Cipla
Novartis
Baxter
Dow
US Department of Justice

Generated: June 27, 2017

DrugPatentWatch Database Preview

Midazolam hydrochloride - Generic Drug Details

« Back to Dashboard

What are the generic sources for midazolam hydrochloride and what is the scope of midazolam hydrochloride freedom to operate?

Midazolam hydrochloride
is the generic ingredient in four branded drugs marketed by Hospira Inc, Wockhardt, Sagent Agila Llc, Apotex Inc, Sagent Strides, Apothecon, Intl Medication, West-ward Pharms Int, Claris, Roche, Intl Medicated, Bedford, Gland Pharma Ltd, Fresenius Kabi Usa, HLR, Ben Venue, Hospira, Hi Tech Pharma, Sun Pharm Inds Ltd, Igi Labs Inc, Paddock Llc, and Akorn Inc, and is included in thirty-six NDAs. There is one patent protecting this compound. Additional information is available in the individual branded drug profile pages.

There are nine drug master file entries for midazolam hydrochloride. Twenty-one suppliers are listed for this compound. There are three tentative approvals for this compound.

Summary for Generic Name: midazolam hydrochloride

Tradenames:4
Patents:1
Applicants:22
NDAs:36
Drug Master File Entries: see list9
Suppliers / Packagers: see list21
Bulk Api Vendors: see list19
Clinical Trials: see list2,943
Patent Applications: see list1,182
Formulation / Manufacturing:see details
Drug Prices:see low prices
DailyMed Link:midazolam hydrochloride at DailyMed

Pharmacology for Ingredient: midazolam hydrochloride

Ingredient-typeBenzodiazepines
Drug ClassBenzodiazepine

Tentative approvals for MIDAZOLAM HYDROCHLORIDE

Applicant Application No. Strength Dosage Form
► Subscribe► SubscribeEQ 5MG BASE/MLINJECTABLE;INJECTION
► Subscribe► SubscribeEQ 5MG BASE/MLINJECTABLE;INJECTION
► Subscribe► SubscribeEQ 5MG BASE/MLINJECTABLE;INJECTION
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Hospira Inc
MIDAZOLAM HYDROCHLORIDE
midazolam hydrochloride
INJECTABLE;INJECTION075409-001Jun 20, 2000DISCNNoNo► Subscribe► Subscribe
Hlr
VERSED
midazolam hydrochloride
INJECTABLE;INJECTION018654-002May 26, 1987DISCNYesNo► Subscribe► Subscribe
Hospira
MIDAZOLAM HYDROCHLORIDE PRESERVATIVE FREE
midazolam hydrochloride
INJECTABLE;INJECTION075857-002Jul 22, 2002APRXNoYes► Subscribe► Subscribe
Gland Pharma Ltd
MIDAZOLAM HYDROCHLORIDE
midazolam hydrochloride
INJECTABLE;INJECTION090696-001Feb 29, 2012APRXNoNo► Subscribe► Subscribe
West-ward Pharms Int
MIDAZOLAM HYDROCHLORIDE
midazolam hydrochloride
INJECTABLE;INJECTION075243-001Jun 20, 2000APRXNoNo► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Expired Orange Book Patents for Generic Ingredient: midazolam hydrochloride

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Roche
VERSED
midazolam hydrochloride
SYRUP;ORAL020942-001Oct 15, 19984,280,957*PED► Subscribe
Hlr
VERSED
midazolam hydrochloride
INJECTABLE;INJECTION018654-001Dec 20, 19854,280,957*PED► Subscribe
Hlr
VERSED
midazolam hydrochloride
INJECTABLE;INJECTION018654-002May 26, 19874,280,957*PED► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Covington
Harvard Business School
Cantor Fitzgerald
US Army
Baxter
Fuji
Novartis
Merck
Deloitte
Express Scripts

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot